How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Sell
32
BUD Quote, Financials, Valuation and Earnings
Last price:
$50.36
Seasonality move
:
0.02%
Day range:
$50.23 - $50.52
52-week range:
$49.66 - $67.49
Dividend yield:
1.73%
P/E ratio:
15.47x
P/S ratio:
1.70x
P/B ratio:
1.26x
Volume:
1.8M
Avg. volume:
2.5M
1-year change:
-22.05%
Market cap:
$99.2B
Revenue:
$59.4B
EPS (TTM):
$3.26
Analysts' Opinion
-
Consensus RatingAnheuser-Busch InBev SA/NV has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 4 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $72.70, Anheuser-Busch InBev SA/NV has an estimated upside of 44.33% from its current price of $50.37.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $60.00 representing -19.12% downside risk from its current price of $50.37.
Fair Value
-
According to the consensus of 8 analysts, Anheuser-Busch InBev SA/NV has 44.33% upside to fair value with a price target of $72.70 per share.
BUD vs. S&P 500
-
Over the past 5 trading days, Anheuser-Busch InBev SA/NV has underperformed the S&P 500 by -1.26% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Anheuser-Busch InBev SA/NV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Anheuser-Busch InBev SA/NV revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Anheuser-Busch InBev SA/NV reported revenues of $15B.
Earnings Growth
-
Anheuser-Busch InBev SA/NV has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Anheuser-Busch InBev SA/NV reported earnings per share of $1.03.
Enterprise value:
178.1B
EV / Invested capital:
--
Price / LTM sales:
1.70x
EV / EBIT:
12.34x
EV / Revenue:
3.00x
PEG ratio (5yr expected):
3.55x
EV / Free cash flow:
78.53x
Price / Operating cash flow:
53.47x
Enterprise value / EBITDA:
12.34x
Gross Profit (TTM):
$32.6B
Return On Assets:
--
Net Income Margin (TTM):
10.99%
Return On Equity:
6.92%
Return On Invested Capital:
--
Operating Margin:
27.19%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $57.3B | $59.6B | $59.4B | $15.6B | $15B | |
| Gross Profit | $31.6B | $32.2B | $32.6B | $8.4B | $8.4B | |
| Operating Income | $14.6B | $14.7B | $15.1B | $4B | $4.1B | |
| EBITDA | $13.3B | $13.9B | $14.4B | $3.6B | $4.2B | |
| Diluted EPS | $2.53 | $3.12 | $3.26 | $0.73 | $1.03 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $1.6B | $2.6B | |
| Cash From Investing | -- | -- | -- | -$2.1B | -$1.7B | |
| Cash From Financing | -- | -- | -- | -$2.8B | -$3.3B | |
| Free Cash Flow | $4.7B | $974M | $2.3B | -$510M | $833M | |
BUD
Sector
Market Cap
$99.2B
$339.9M
Price % of 52-Week High
74.63%
73.76%
Dividend Yield
1.73%
0%
Shareholder Yield
--
2.64%
1-Year Price Total Return
-22.05%
-13.42%
Beta (5-Year)
1.083
0.504
Dividend yield:
1.73%
Annualized payout:
$0.82
Payout ratio:
32.83%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$50.75
200-day SMA
Sell
Level
$60.42
Bollinger Bands (100)
Sell
Level
54.97 - 64.73
Chaikin Money Flow
Buy
Level
160.4M
20-day SMA
Sell
Level
$52.32
Relative Strength Index (RSI14)
Sell
Level
25.05
ADX Line
Buy
Level
12.1
Williams %R
Buy
Level
-83.6028
50-day SMA
Sell
Level
$56.67
MACD (12, 26)
Sell
Level
-1.72
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Sell
Level
-204.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.2784)
Sell
CA Score
(Annual)
Level (-0.7185)
Buy
Beneish M-Score
(Annual)
Level (-2.4237)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.0507)
Buy
Piotroski F Score
(Annual)
Level (6)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, according to Euromonitor, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev and in 2016 it acquired SABMiller.
Stock Forecast FAQ
In the current month, BUD has received 4 Buy ratings 4 Hold ratings, and 0 Sell ratings. The BUD average analyst price target in the past 3 months is $72.70.
-
Where Will Anheuser-Busch InBev SA/NV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Anheuser-Busch InBev SA/NV share price will rise to $72.70 per share over the next 12 months.
-
What Do Analysts Say About Anheuser-Busch InBev SA/NV?
Analysts are divided on their view about Anheuser-Busch InBev SA/NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Anheuser-Busch InBev SA/NV is a Sell and believe this share price will drop from its current level to $60.00.
-
What Is Anheuser-Busch InBev SA/NV's Price Target?
The price target for Anheuser-Busch InBev SA/NV over the next 1-year time period is forecast to be $72.70 according to 8 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is BUD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Anheuser-Busch InBev SA/NV is a Leans Bullish. 4 of 8 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of BUD?
You can purchase shares of Anheuser-Busch InBev SA/NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Anheuser-Busch InBev SA/NV shares.
-
What Is The Anheuser-Busch InBev SA/NV Share Price Today?
Anheuser-Busch InBev SA/NV was last trading at $50.36 per share. This represents the most recent stock quote for Anheuser-Busch InBev SA/NV. Yesterday, Anheuser-Busch InBev SA/NV closed at $50.37 per share.
-
How To Buy Anheuser-Busch InBev SA/NV Stock Online?
In order to purchase Anheuser-Busch InBev SA/NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 49.62% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is up 10.88% over the past day.
